Assess in Biological Technology

Latest BioTrends Research Reports to Assess the Impact of the Withdrawal of Raptiva (efalizumab) on the Psoriasis Market

EXTON, Pa., April 10 /PRNewswire/ -- On April 8th, 2009, Genentech and Roche announced the voluntary withdrawal of Raptiva (efalizumab, marketed by Genentech/Roche and Xoma) from the US market. The withdrawal comes after recent post-marketing reports of PML associated with Raptiva treatment. ...

Alimera Sciences Begins Pilot Study to Assess Safety and Efficacy of Iluvien(TM) in Patients With Bilateral Geographic Atrophy Due to AMD

ATLANTA, Dec. 11 /PRNewswire/ -- Alimera Sciences Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported that enrollment has begun for a pilot study to assess the safety and eff...

CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities

SARASOTA, Fla., Sept. 29 /PRNewswire-FirstCall/ -- CPC of America, Inc. (OTC Bulletin Board: CPCF.OB) today announced that it had retained FTI Capital Advisors, LLC, the investment banking subsidiary of FTI Consulting, Inc., to explore strategic alternatives for the Company. As CPC of Americ...

Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk

FREMONT, Calif., March 3 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML ), a high-value molecular diagnostics company, announced today that it has entered into an exclusive license agreement with Stanford University to develop and commercialize a novel biomarker panel used to assess...

VoIP experts assess early implementations

MADISON Phone calls over the Internet are no longer a pipe dream. That was the message of Accelerate Madison s May 20 presentation, a panel discussion of Voice over Internet Protocol, or VoIP. VoIPs ability to carry phone conversations over existing data networks has stirred excitement over th...

Entrepreneurs learn to assess potential ideas

MILWAUKEE The Wisconsin Entrepreneurs Conference continued providing industrialists with tips on how to flourish in a competitive market, with a seminar held Wednesday to provide information on assessing the market potential of ideas. Entrepreneurs and industry representatives listened to a boar...

A New Way to Assess siRNA Delivery Efficiency

Assess GAPDH siRNA delivery in less time for a fraction of the cost of real-time PCR Analyze from one to 96 samples simultaneously Measure both GAPDH siRNA-induced knockdown AND transfection-induced toxicity Use with Silencer ...

Advancing the quality control methodology to assess isolated total RNA and generated fragmented cRNA

This Application Note describes how Gene Logic, Inc., has improved its ability to analyze the quality of total RNA and fragmented cRNA by using the Agilent 2100 bioanalyzer. The Eukaryote Total RNA Nano and Pico assays ar...

Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody

... and promoting cell differentiation. OMP-21M18 is currently in a Phase 1 clinical trial in patients with advanced solid tumors. This trial will also assess pharmacokinetics and provide initial indications of efficacy. OMP-21M18 is part of OncoMed's Notch pathway collaboration with GlaxoSmithKline. ...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

... prospective clinical trial. The purpose of the clinical trial was to evaluate the device's safety and efficacy in preventing pulmonary emboli, and to assess the ability to retrieve the device from the body up to 175 days following implantation. The results, representing a total of 100 patients, were presen...

Repligen Reports First Quarter Fiscal Year 2010 Financial Results

...n a Phase 3 clinical trial of RG1068, synthetic human secretin, designed to assess the ability of RG1068 in combination with magnetic resonance imaging (MRI) ... RG2417 or a placebo twice a day for eight weeks. The study is designed to assess the safety and efficacy of RG2417 on the symptoms of depression as measured...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

... data from these activities throughout the remainder of 2009. Preclinical Chaperone Programs Amicus continues to invest in research to assess the potential for applying its versatile chaperone technology platform to the treatment of a broad range of human genetic diseases. As part of this ef...

Pharmasset to Present at Canaccord Adams Conference

... is in a Phase 2b clinical trial in combination with Pegasys(R) plus Copegus(R) and is also in INFORM studies, the first series of studies designed to assess the potential of combinations of small molecules without Pegasys(R) and Copegus(R) to treat chronic HCV. These clinical studies are being conducted th...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

...of 2009 as planned. We are also initiating Phase 2 pilot clinical trials to assess the efficacy and safety of VYVANSE in non ADHD ("Attention Deficit Hyperact...tions in adults - Shire is conducting Phase 2 pilot clinical trials to assess the efficacy and safety of VYVANSE as adjunctive therapy in depressio...

New Director of Lab Sales for Polymathic Analytical Labs

...eadership within competitive markets," said Chris Given, Laboratory Manager. "With Bill's expertise and proven track record, we will be better able to assess the needs of our partners, meet customer demands and maintain lasting business relationships." Kerr is a graduate of the University of Pittsbur...

AEterna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma

...at the Phase 3 study design adequately addresses objectives in support of a regulatory submission. The study, entitled, "A Phase 3 Randomized Study to assess the Efficacy and Safety of Perifosine Added to the Combination of Bortezomib and Dexamethasone in Multiple Myeloma Patients Previously Treated with Bo...

Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria

...rial to evaluate ARIKACE in patients with NTM lung disease who have failed to respond to standard, guideline-based treatment regimens. The study will assess the safety and tolerability of ARIKACE versus placebo administered once daily for several continuous months using an investigational eFlow(R) Nebulize...

PROTOMED SA Chooses HyperWorks to Simulate Implantable Medical Devices

...ous applications, ranging from coronary stents to orthopedics implant. "We were looking for a high-performance finite element analysis tool to assess mechanical resistance limits in relation to our European device development and test services activities," said Frederic Mouret, CEO and founder of PR...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

...ors to demonstrate the company's ability to comply with financial debt covenants (which are calculated using a measure similar to adjusted EBITDA) and assess the company's ability to incur additional indebtedness. Whenever Mylan uses such a non-GAAP measure, it will provide a reconciliation of non-GAAP fina...

U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International

...re International are disappointed with the FTC's decision to challenge the acquisition. The companies intend to review the FTC's decision and mutually assess the appropriate next steps and promptly communicate their intentions once a decision has been made. About Thoratec Corporation Thoratec C...

Sanofi-aventis Announces Second Quarter 2009 Results

...ng the primary concern of sanofi-aventis, the company commissioned a board of international specialists in endocrinology, oncology and epidemiology to assess these analyses of registries. On July 15, this board issued an expert statement which concluded that the four studies had significant methodological l...

United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients

...Derived Factor - 1) to treat congestive heart failure. The REGEN trial will enroll 15 patients in a multicenter, randomized, dose escalation study to assess the safety and cardiovascular effects of the implantation of MyoCell SDF-1 in congestive heart failure patients post myocardial infarction(s). ...

PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2

...ents with NF2 for up to 48 weeks. The primary objective of the study is to assess how PTC299 affects tumor volume and changes in hearing and word recognition among patients with NF2. The trial will also assess the effects of PTC299 on tumor blood flow and VEGF-related proteins. The s...

Thomson Reuters Announces 2009 Edition of the CMR International Pharmaceutical R&D Factbook

...and corporate communications professionals. Since 1994, CMR International has worked with leading global pharmaceutical and biotechnology companies to assess R&D productivity and provide insights which help organizations to improve the planning and effectiveness of R&D. The information publ...

Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration

...he second group received placebo the first week and their optimal dose of Vyvanse the second week. The primary objective of this study was to assess the time of onset of Vyvanse compared with placebo, as measured by the Swanson, Kotkin, Agler, M-Flynn, and Pelham Deportment (SKAMP-D) rating scale. ...

Magellan Diagnostic Businesses to Feature Automated Systems and Diagnostic Tests at Clinical Lab Expo

...e testing. To see a video of the DS2 at work, visit www.dynextechnologies.com . ESA Life Sciences will feature its FDA-cleared test to assess vitamin D sufficiency, a practical, cost-effective alternative to send-out tests that offers significant improvements over other methodologies. The E...

Thomson Reuters Partners With Sagient Research

..., providing a combination of data to help biopharma companies and investors assess new drugs. The product will be the first on the market to put forecasting...nsing activity and more scrutiny on drug development, our customers need to assess sales potential of new drugs more often than ever before," said Jon Brett-H...

DermTech and Stiefel Laboratories, Inc. to Further Evaluate EGIR(TM) Technology

.... The two companies will now move forward with a proof-of-concept study to assess the use of the technology to understand the pathophysiology of acne. ...tic-based technology and believe it will appropriately be the first ever to assess the relationship between genetic changes in the skin over time and the obse...

Vasogen Announces Second Quarter 2009 Results

...e any such agreements. The Board will also consider alternatives to these that it has also been evaluating. The Board will continue to assess the merits of these options relative to liquidating the Company and distributing the remaining cash to the shareholders. The una...

Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease

...esearch, measurement, and documentation of the growing burden of care and cost of Alzheimer's disease to adequately provide support for caregivers and assess patient healthcare needs," said Dr. Dale P. Schenk, Executive Vice President and Chief Scientific Officer of Elan. "Elan and Wyeth, through the Alzhei...

Brazil's Scientific Research On The Rise, Thomson Reuters Study Finds

...-- are the countries possessing the resources and economic potential to capture a significant share of the world's future economic growth. To assess Brazil's research, Science Watch turned to publication and citation statistics compiled in the Thomson Reuters National Science Indicators databas...

Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment

...e of the study was the average of postdose PERMP total scores in adults taking VYVANSE compared to placebo. The key secondary efficacy measure was to assess the duration of efficacy of VYVANSE compared to placebo using PERMP; the PERMP total score is the sum of the number of math problems attempted (PERMP-...

Biovista Inc. Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-601 Repositioned Drug for Epilepsy

...levant unmet medical needs. Biovista's proprietary repositioning technology allows it to perform mechanism-of-action based analyses and systematically assess clinical outcomes in any therapeutic area of interest, at relatively low cost and short time spans. The company is presently using this platform to de...

Advanced Life Sciences' Restanza(TM) Shows 100% Survival In Confirmatory Anthrax Study

...cted in animals alone. The non-human primates used in the study referenced above were used to help understand anthrax disease mechanisms and to assess novel approaches for the prophylactic treatment of inhalation anthrax in lieu of human efficacy testing pursuant to FDA's "Animal Efficacy Rule" (21 C...

New Generation Biofuels Signs Letter of Intent with Instituto Costarricense de Electricidad (ICE) of Costa Rica

...th biofuel produced in its production facility located in Baltimore, Maryland, for the testing program. An additional evaluation will be conducted to assess the availability within Costa Rica of palm oil, Jatropha, or animal fats suitable for use as feedstock to produce biofuel. About Instituto Cos...

Fallopian tubes offer new stem cell source

...e at the University of So Paulo, directed by Mayana Zatz, with the collaboration of medical doctors from the reproductive area, set out to isolate and assess the differentiation potential of mesenchymal stem cells from discarded human fallopian tubes. In the study, human fallopian tubes were obtained from h...

European Airports Actively Engaging on Reducing CO2, Despite the Crisis

... EUROPE Annual Congress taking place in Manchester sees ACI EUROPE deliver on that promise, at a critical time. Airport Carbon Accreditation will assess and recognise airports' efforts to manage and reduce CO2 emissions within their direct control. It will also take into account collaborative efforts w...

Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer

...n objectives of the open label dosing and dosimetry study are to confirm the maximum tolerated dose of Cotara, to determine radiation dosimetry and to assess overall patient survival, progression free survival and the proportion of patients alive at six months following Cotara administration. In this study...

Phase 3 Cystic Fibrosis Trial Results Presented at European Conference

... Australia and New Zealand. The primary endpoint of the trial was to assess whether Bronchitol improves lung function as measured by a change in FEV1 w...r day for six months. The key secondary endpoint of the trial was to assess whether Bronchitol further improves lung function in patients already being...

AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule

...is. The safety study (041) titled, "Cetrorelix pamoate in patients with symptomatic BPH: an open-labeled safety and efficacy assessment study", will assess an intermittent dosage regimen of cetrorelix pamoate as a potential safe and tolerable treatment providing prolonged improvement in BPH-related signs ...